'Young blood' Alzheimer's treatments slapped with warning by FDA commissioner

After the FDA warned about "young blood" purporting to treat a range of diseases, including Alzheimer's and post-traumatic stress disorder, a company with a clinical operation in San Francisco has ceased its treatments.